1
|
Santos-Simarro F, Pacio M, Cueto-González AM, Mansilla E, Valenzuela-Palafoll MI, López-Grondona F, Lledín MD, Schuffelmann C, Del Pozo Á, Solis M, Vallcorba P, Lapunzina P, Menéndez Suso JJ, Siccha SM, Montejo JM, Mena R, Jiménez-Rodríguez C, García-Miñaúr S, Palomares-Bralo M. Mosaic Variegated Aneuploidy syndrome 2 caused by biallelic variants in CEP57, two new cases and review of the phenotype. Eur J Med Genet 2021; 64:104338. [PMID: 34500087 DOI: 10.1016/j.ejmg.2021.104338] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2021] [Revised: 09/01/2021] [Accepted: 09/04/2021] [Indexed: 11/20/2022]
Abstract
Mosaic Variegated Aneuploidy Syndrome 2 (MVA2; MIM 614114) is a rare autosomal recessive disorder, characterized by mosaic aneuploidies involving multiple chromosomes and tissues, caused by biallelic pathogenic variants in the CEP57 gene. Only 10 patients have been reported to date. We report two additional non related cases born to Moroccan consanguineous parents, carrying the previously described c.915_925dup11 CEP57 homozygous variant. Common features of these 12 cases include growth retardation, typically of prenatal onset, distinctive facial features, endocrine, cardiovascular and skeletal, abnormalities while malignancies have not been reported. This report describes the phenotypical spectrum of MVA2.
Collapse
Affiliation(s)
- Fernando Santos-Simarro
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain; European Reference Network, ERN ITHACA, Spain.
| | - Marta Pacio
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain; European Reference Network, ERN ITHACA, Spain.
| | - Anna María Cueto-González
- Departamento de Genética Clinical y Molecular,Grupo de Genética Médica, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Institut de Recerca (VHIR), Hospital Universitari, Vall d'Hebron, Barcelona, Spain; European Reference Network, ERN ITHACA, Spain; European Reference Network, ERN CRANIO, Spain.
| | - Elena Mansilla
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain; European Reference Network, ERN ITHACA, Spain.
| | - María Irene Valenzuela-Palafoll
- Departamento de Genética Clinical y Molecular,Grupo de Genética Médica, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Institut de Recerca (VHIR), Hospital Universitari, Vall d'Hebron, Barcelona, Spain; European Reference Network, ERN ITHACA, Spain.
| | - Fermina López-Grondona
- Departamento de Genética Clinical y Molecular,Grupo de Genética Médica, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Institut de Recerca (VHIR), Hospital Universitari, Vall d'Hebron, Barcelona, Spain.
| | - María Dolores Lledín
- Servicio de Hepatología Pediátrica, Hospital Universitario La Paz, Madrid, Spain.
| | - Cristina Schuffelmann
- Servicio de Cuidados Intensivos Pediátricos, Hospital Universitario La Paz, Madrid, Spain.
| | - Ángela Del Pozo
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain.
| | - Mario Solis
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain.
| | - Patricia Vallcorba
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain; European Reference Network, ERN ITHACA, Spain.
| | - Pablo Lapunzina
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain; European Reference Network, ERN ITHACA, Spain.
| | | | - Sofia M Siccha
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
| | - Juan Manuel Montejo
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain.
| | - Rocío Mena
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain.
| | - Carmen Jiménez-Rodríguez
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
| | - Sixto García-Miñaúr
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain; European Reference Network, ERN ITHACA, Spain.
| | - María Palomares-Bralo
- Instituto de Genética Medica y Molecular (INGEMM), Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), ISCIII, Madrid, Spain; European Reference Network, ERN ITHACA, Spain.
| |
Collapse
|